Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. - Wikidata - awgldk - TriplyDB

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

http://www.wikidata.org/entity/Q33534845

about

Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.HIV-Associated Tuberculosis.Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda.Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center.Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.Tuberculosis: burning issues: multidrug resistance and HIV-coinfection.Novel diagnostics and therapeutics for drug-resistant tuberculosis.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Developing a customised approach for strengthening tuberculosis laboratory quality management systems toward accreditation.Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis.Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study.Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay.Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level.Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study.OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport.Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.Rapid molecular assays for detection of tuberculosis.Phenotypic and genotypic drug sensitivity of complex isolated from South Omo Zone, Southern Ethiopia Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen t

P2860

Q26824812-FEC478AF-CC8E-40D9-A7C0-EB3928F38BD3 Q28478104-457F3A1D-591D-4A79-BB51-516DB2B0E500 Q28481689-670C357B-2597-43D5-89D5-EFB713D16493 Q28534875-CDE07E84-1864-44DF-B597-85A7ABFFE4AD Q28536857-C87FD112-93F5-4704-9819-6EE14FDC4395 Q28539890-02A08A98-7897-475A-BECC-9809C206A3FC Q28550477-C9678711-D885-4459-9721-135044A811B8 Q28552779-9398D259-4B9B-497E-8D10-090DB025BE8A Q33568441-F8837B61-72D3-4A47-A4A8-D8258F3AD147 Q33658873-5FBD0883-24FD-4618-BEDC-ABEAA8F5D1BA Q34143510-76388A29-63BD-4F73-BAD0-2AA5F0442CBE Q34224000-AE2F19AC-08D6-4D9A-9D5A-07FDA087015C Q34588310-CA613FBB-D5F9-4439-8E84-303564D3567F Q34775445-173C405D-14FD-426D-AC4E-17A2008569B7 Q35107029-22F8DBC7-13CC-411C-9568-A778C4CC954F Q35584136-37738E02-740A-4A91-A567-345AF9F8FCB4 Q35768714-2CB04E3C-7D33-464C-BFB8-0FE4FBA9295F Q35971268-64ECBCC4-9827-4EBC-8BB2-9EABE432A7AC Q36118693-E5CA8D07-AF44-43F2-9E52-12485D2EC971 Q37218623-75936FEC-EB13-4E45-8378-7999128D82BA Q37423406-58D67B4A-650D-4BAC-931C-6655AC2DAC15 Q37581864-E87EBB52-9A96-4BE0-9594-E907C8A9972B Q37993974-03F6A140-92B4-46B8-9B45-4547EF6A043E Q38210363-AFD0B282-C75E-4F0E-B08C-395F4619884E Q39094119-F383DF4D-56D0-4166-AC03-92E0B9CD10B7 Q41103395-407E6C91-1C86-46C9-851B-E1038FF5247D Q43209788-FCBB3003-32C8-4CF3-815E-FD8B71CFBAB4 Q43708616-010CA2BE-EFEF-4074-A5B4-C810823DFF9A Q45916508-64563ACF-5BE2-473B-B011-0C6A883CD9A9 Q47127410-307DB0A0-8F90-4502-8968-4EDB6F071B95 Q52836593-3B969EFF-E0D8-418D-9717-945B37CE062B Q53702265-C25AE3DA-EA61-4DC0-B25A-951AA8D918C4 Q55260133-1FF7EFA5-EC25-44B2-BC43-62511BC34A22 Q55366967-59228330-D0D4-4577-AFC9-E1C9F7F4BA75 Q57069790-D3C28CFC-3CBF-41D4-B49B-DC8A55D7E600 Q57212971-FC53C69F-4773-4F4B-AF9C-646B418FD28A

P2860

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

http://www.wikidata.org/entity/Q33534845

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@ast

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@en

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@nl

type

label

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@ast

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@en

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@nl

prefLabel

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@ast

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@en

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@nl

P1433

Q33534845-632BF449-A7F9-46B5-B0A6-3583F2C7B651

P1476

Q33534845-E30DD860-C2A4-40AC-9BCA-EDD3FCA0FD0D

P2093

Q33534845-0FB8AA1C-238B-4571-80CB-7A670C205CA2

Q33534845-42C77150-81DB-46FA-A922-2C6FC92F1A8C

Q33534845-5B997181-4D70-414D-A2BB-B21386FE1049

Q33534845-625377E6-055E-47B1-A46A-51E7E3A666E3

Q33534845-7683A8EF-3976-44A3-B04F-28C287C6FF82

Q33534845-AE984743-67ED-4879-AA9A-88432CB4308A

Q33534845-B81AF979-2351-4BFF-A579-04D64499FD51

Q33534845-D1859CC9-5DDF-441B-BD7C-0A498D622862

Q33534845-D724B832-EF36-413E-884A-672508B8C56B

P2860

Q33534845-05987003-F9EE-495D-BD50-D49C4FF6E048

Q33534845-0ED1B1A6-BD5D-41F8-AAAD-D6339D84784D

Q33534845-219D445D-8E79-4A37-AEC5-2977BD42D4CF

Q33534845-274B0BE5-3FB2-4320-89D0-930E1872EA33

Q33534845-3FEDF046-6ECD-43FA-A2FD-1E7904F0204E

Q33534845-55F349D1-5625-47E5-AF30-7F5258C7BA54

Q33534845-5AF36A5E-EB1E-4405-960D-DB31359A5590

Q33534845-976310E6-DFA0-45FD-A82D-DD16151C16C5

P2888

Q33534845-9E6A2184-513F-43D5-AC67-142307FFE2B3

P304

Q33534845-27823849-0F29-47EE-9DE7-CC38E4ED5B2E

P31

Q33534845-B8D7F045-499E-4947-B5DC-5AB75BA4F334

P356

Q33534845-7BA5F750-F6D7-48C9-A319-87955DDBE6FC

P478

Q33534845-117A4C56-094B-46EB-93EA-4C7C630F5EF6

P50

Q33534845-42D908E5-A2C3-4616-ACE3-2DB6BE24ADE7

P577

Q33534845-7F3B8FEC-0151-4D8C-B251-1E2D75ECA4E7

P5875

Q33534845-E5F95F1E-DD39-40FA-81A6-0F9EEEEF6C6C

P6179

Q33534845-A6E63B39-8F65-41E6-BBC3-CE855C9546FE

P698

Q33534845-EFC781CB-C518-4406-9251-79EEE9E0CBE1

P921

Q33534845-9CEC2919-23A8-4C3F-B6AF-AF155181D42A

P932

Q33534845-9F03BC67-E7F5-42B2-A625-A776C1145DC1

P356

1471-2334-10-41

P1433

BMC Infectious Diseases

P1476

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.

@en

P2093

Barnabas Nyesiga

http://www.w3.org/2001/XMLSchema#string

Freddie Bwanga

http://www.w3.org/2001/XMLSchema#string

George Lukyamuzi

http://www.w3.org/2001/XMLSchema#string

Heidi Albert

http://www.w3.org/2001/XMLSchema#string

Julius Patrick Ademun

http://www.w3.org/2001/XMLSchema#string

Melles Haile

http://www.w3.org/2001/XMLSchema#string

Richard O'Brien

http://www.w3.org/2001/XMLSchema#string

Sheena Mukkada

http://www.w3.org/2001/XMLSchema#string

Sven Hoffner

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism

Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community

High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

P2888

1471-2334-10-41

P304

41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-10-41

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41620525

http://www.w3.org/2001/XMLSchema#string

P6179

1001076104

http://www.w3.org/2001/XMLSchema#string

P698

20187922

http://www.w3.org/2001/XMLSchema#string

P921

P932

2841659

http://www.w3.org/2001/XMLSchema#string